The AI was trained on a database of 5.1 million CRISPR-associated (Cas) proteins, allowing it to create potential molecules ...
Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators are trying to make the process more efficient using artificial intelligence.
Initially to treat a rare disease called phenylketonuria —To design a natural killer cell therapy heavily engineered to ...
Today, we announce the successful editing of DNA in human cells with gene editors fully designed with AI. Not only that, we've decided to freely release the molecules under the @ProfluentBio ...
Out of a group of 100 people judged at highest risk by the AI program, 74 very likely have a rare immune disorder FRIDAY, May 3, 2024 (HealthDay News) -- Artificial intelligence might be able to ...
The US Centers for Medicare & Medicaid Services (CMS) has announced proposals to improve access to gene therapies that have recently been approved for use in the USA for the treatment of sickle cell ...
USA-based rare seizure specialist Marinus Pharmaceuticals saw its shares crash, falling nearly 83% to $1.36, after it revealed that a trial failed to meet early stopping criteria. The US Centers for ...